BRAIN CANCER

Our goal is to expand our scientific excellence and embolden our community of scholars to tackle this devastating disease by providing a framework that is bolstered by state-of-the-art research infrastructure and an expansive range of scientific and community-building activities... Led by co-directors, Maria Castro and Steve Schwendeman, this initiative nucleated at a Biointerfaces Institute Challenge workshop in 2013. Our team represents an interdisciplinary group of technologists and brain cancer experts who are actively collaborating on multiple research projects and have successfully translated new promising technologies to clinical studies to treat brain cancer patients... Gliomas are the most prevalent primary brain cancers in adults. Glioblastoma multiforme (GBM) is specifically a devastating disease with a poor prognosis. It is classified as a WHO grade IV tumor, accounting for 82% of all malignant gliomas. There have been many attempts to overcome the challenges of GBM..

Primary location: Ann Arbor United States